{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:52:19Z","timestamp":1789505539242,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.xops.2025.100794","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:58:13Z","timestamp":1744372693000},"page":"100794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Plasma Proteomic Markers of Interleukin-1\u03b2 Pathway Associated with Incident Age-Related Macular Degeneration in Persons with AIDS"],"prefix":"10.1016","volume":"5","author":[{"given":"Peter W.","family":"Hunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam B.","family":"Olshen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle C.","family":"Ambayec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efe","family":"Sezgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0368-1361","authenticated-orcid":false,"given":"Douglas A.","family":"Jabs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2025.100794_bib1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jamaophthalmol.2013.2303","article-title":"C-reactive protein and the incidence of macular degeneration","volume":"131","author":"Mitta","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2025.100794_bib2","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archopht.122.7.1013","article-title":"Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization?","volume":"122","author":"Cousins","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2025.100794_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.survophthal.2005.12.001","article-title":"The role of inflammation in the pathogenesis of age-related macular degeneration","volume":"51","author":"Donoso","year":"2006","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.xops.2025.100794_bib4","first-page":"E112","article-title":"Variations in TIMP3 are associated with age related macular degeneration","volume":"117","author":"Kaur","year":"2010","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.xops.2025.100794_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xops.2025.100794_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1086\/323898","article-title":"Clinical indicators of immune restoration following antiretroviral therapy","volume":"34","author":"Cooney","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xops.2025.100794_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Viral Activation Transfusion Study Investigators. Antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"Murphy","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.xops.2025.100794_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2010.10.018","article-title":"Cytomegalovirus retinitis and the acquired immune deficiency syndrome: bench to bedside: LXVII Edward Jackson Memorial Lecture","volume":"151","author":"Jabs","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100794_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7326\/0003-4819-146-2-200701160-00003","article-title":"Survival of persons with and without HIV infection in Denmark, 1995-2005","volume":"146","author":"Lohse","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.xops.2025.100794_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies","volume":"372","author":"Hogg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2025.100794_bib11","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xops.2025.100794_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.xops.2025.100794_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/gerona\/glt168","article-title":"Is HIV a model of accelerated or accentuated aging?","volume":"69","author":"Pathai","year":"2014","journal-title":"J Gerontol A Biol Sci Med"},{"key":"10.1016\/j.xops.2025.100794_bib14","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4049\/jimmunol.180.3.1499","article-title":"Homeostasis of the naive CD4+ T cell compartment during aging","volume":"180","author":"Kilpatrick","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.xops.2025.100794_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-407707-2.00002-3","article-title":"Immune dysregulation syndrome in treated HIV infection","volume":"119","author":"Lederman","year":"2013","journal-title":"Adv Immunol"},{"key":"10.1016\/j.xops.2025.100794_bib16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/infdis\/jiu238","article-title":"Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection","volume":"210","author":"Hunt","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.xops.2025.100794_bib17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ajo.2015.01.037","article-title":"Prevalence of intermediate-stage age-related macular degeneration in patients with the acquired immunodeficiency syndrome","volume":"159","author":"Jabs","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100794_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2017.05.004","article-title":"Incidence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome","volume":"179","author":"Jabs","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100794_bib19","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.ophtha.2014.06.014","article-title":"Studies of the Ocular Complications of AIDS Research Group. Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections","volume":"121","author":"Kempen","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100794_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/QAD.0000000000003104","article-title":"Association of elevated plasma inflammatory biomarker levels with age-related macular degeneration but not cataract in persons with AIDS","volume":"36","author":"Jabs","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.xops.2025.100794_bib21","article-title":"Association of intermediate-stage age-related macular degeneration with plasma inflammatory biomarkers in persons with AIDS","volume":"4","author":"Jabs","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2025.100794_bib22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ophtha.2006.11.008","article-title":"For the studies of the ocular Complications of AIDS research group. Longitudinal study of the ocular Complications of AIDS: 1. Ocular diagnoses at enrollment","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100794_bib23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0002-9394(01)01218-1","article-title":"The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report number 6","volume":"132","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100794_bib24","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archopht.123.11.1484","article-title":"The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17","volume":"123","author":"Davis","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2025.100794_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xops.2025.100794_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B"},{"key":"10.1016\/j.xops.2025.100794_bib27","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xops.2025.100794_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.xops.2025.100794_bib29","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1016\/j.devcel.2024.09.006","article-title":"Human iPSC-based disease modelling studies identify a common mechanistic defect and potential therapies for AMD and related macular dystrophies","volume":"59","author":"Dalvi","year":"2024","journal-title":"Dev Cell"},{"key":"10.1016\/j.xops.2025.100794_bib30","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","article-title":"Proteolytic processing of IL-1family cytokines: variation on a common theme","volume":"42","author":"Afonina","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.xops.2025.100794_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.xops.2025.100794_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2012.05.005","article-title":"Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells \u2013 implications for age-related macular degeneration (AMD)","volume":"147","author":"Kauppinen","year":"2012","journal-title":"Immunol Lett"},{"key":"10.1016\/j.xops.2025.100794_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-319-17121-0_9","article-title":"The NLRP3 inflammasome and its role in age-related macular degeneration","volume":"854","author":"Ildefonso","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.xops.2025.100794_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/tvst.9.13.27","article-title":"Inflammasome proteins and inflammatory biomarkers for age-related macular degeneration","volume":"9","author":"Weaver","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.xops.2025.100794_bib35","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Anti-inflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xops.2025.100794_bib36","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the sub-distribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.xops.2025.100794_bib37","series-title":"Risk Assessment and Evaluation of Predictions","first-page":"3","article-title":"Non-proportionality of hazards in the competing risk framework","author":"Munoz","year":"2013"}],"updated-by":[{"DOI":"10.1016\/j.xops.2025.100974","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000}},{"DOI":"10.1016\/j.xops.2025.100974","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000}}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525000922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525000922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T19:43:49Z","timestamp":1772048629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914525000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2666914525000922"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2025.100794","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma Proteomic Markers of Interleukin-1\u03b2 Pathway Associated with Incident Age-Related Macular Degeneration in Persons with AIDS","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2025.100794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100794"}}